NCT01735825View on ClinicalTrials.gov

Treatment of Coronary In-Stent Restenosis

NACompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

June 30, 2018

Conditions
Restenosis
Interventions
DEVICE

paclitaxel-coated balloon catheter with Iopromide coating

Patients with coronary in-stent restenosis treated by drug eluting paclitaxel-coated balloon catheter

DEVICE

drug eluting stent with everolimus

Patients with coronary in-stent restenosis treated by drug eluting stent with everolimus

DEVICE

seal-wing paclitaxel-eluting balloon catheter

Patients with coronary in-stent restenosis treated by seal-wing paclitaxel-eluting balloon catheter

Trial Locations (1)

708 52

University Hospital, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT01735825 - Treatment of Coronary In-Stent Restenosis | Biotech Hunter | Biotech Hunter